Hrt Financial LP Brainstorm Cell Therapeutics Inc. Transaction History

Hrt Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.81 - $4.23 $228,984 - $344,698	-81,489 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$3.14 - $4.09 $14,155 - $18,437	-4,508 Reduced 5.24%	81,489 $268,000
Q2 2021 Aug 16, 2021	BUY	$3.01 - $4.01 $258,850 - $344,847	85,997 New	85,997 $326,000
Q1 2021 May 17, 2021	SELL	$3.46 - $7.88 $92,132 - $209,828	-26,628 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.99 - $17.73 $106,245 - $472,114	26,628 New	26,628 $120,000

10.5M

160K

30.5K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $69.3M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.